Compounds > triethylenemelamine
Page last updated: 2024-11-06

triethylenemelamine and Thrombopenia

triethylenemelamine has been researched along with Thrombopenia in 3 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DRAGANESCU, CI1
GOGA-IONESCU, S1
CSAP, CF1
COPORAN, R1
Silver, RT1
Weinreich, J1

Reviews

1 review available for triethylenemelamine and Thrombopenia

ArticleYear
The treatment of chronic lymphocytic leukemia.
    Seminars in hematology, 1969, Volume: 6, Issue:4

    Topics: Adrenal Cortex Hormones; Alkylating Agents; Anemia; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Ag

1969

Other Studies

2 other studies available for triethylenemelamine and Thrombopenia

ArticleYear
[RESULTS OBTAINED IN TWO CASES OF SEVERE LEUKOTHROMBOPENIA WITH A HEMORRHAGIPAROUS SYNDROME, APPEARING AFTER ADMINISTRATION OF CYTOSTATICS, TREATED WITH HOMOLOGOUS HEMATOPOIETIC TISSUE].
    Medicina interna, 1963, Volume: 15

    Topics: Antineoplastic Agents; Bone Marrow Transplantation; Breast Neoplasms; Cytostatic Agents; Ecchymosis;

1963
[Autoimmune hemolytic anemia and as a result of x-ray and cytostatic treatment in lymphatic leukemia].
    Allergie und Asthma, 1967, Volume: 13, Issue:6

    Topics: Anemia, Hemolytic, Autoimmune; Humans; Immune Tolerance; Leukemia, Lymphoid; Male; Middle Aged; Radi

1967